Published October 26, 2015
| Version v1
Presentation
Open
Analysing NGS data with clinical data in a translational medicine setting: tranSMART and cBioPortal
Description
The use of Next Generation Sequencing in Translational Medicine is very diverse, but falls into two basic categories: clinical applications and research. In both settings, the combination of sequencing data with patient data generates its own set of challenges both from a legal and operational as well as from a data management, storage and analytics perspective.
In this talk, the emergence of a number of popular open source platforms for analyzing genomics data in a translational setting will be discussed, specifically tranSMART and cBioPortal. Both tools are used by an increasing number of pharma companies and medical centers, and are popular in public-private consortia as a means to provide a common repository and analytics interface for clinical and genomics data, next to public repositories such as dbGaP and EGA.
The speaker is founder and CEO of The Hyve, a 30-person open source bioinformatics company with offices in Utrecht and Boston that provides professional support for open source software for bioinformatics, clinical and translational research.
In this talk, the emergence of a number of popular open source platforms for analyzing genomics data in a translational setting will be discussed, specifically tranSMART and cBioPortal. Both tools are used by an increasing number of pharma companies and medical centers, and are popular in public-private consortia as a means to provide a common repository and analytics interface for clinical and genomics data, next to public repositories such as dbGaP and EGA.
The speaker is founder and CEO of The Hyve, a 30-person open source bioinformatics company with offices in Utrecht and Boston that provides professional support for open source software for bioinformatics, clinical and translational research.